(E)-N-(2-amino-phenyl)-3-{1-[4-(l-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts

A mesylate salt of (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide in its polymorphic form A, which has powder X-ray diffraction peaks at:

• 3.9, 16.4 and 16.9±0.1 (°2θ);
• or
• a hemi ethane-1,2-disulfonate salt of (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide in its polymorphic form A, which has powder X-ray diffraction peaks at:
• 16.0, 22.7 and 25.1±0.1 (°2θ);
• or
• a besylate salt of (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide in its polymorphic form A, which has powder X-ray diffraction peaks at:
• 19.1 , 20.4 and 22.7±0.1 (°2θ);
• or
• a toluenesulfonate salt of (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide in one of the following polymorphic forms:
• polymorphic form A, which has powder X-ray diffraction peaks at:
• 7.0, 19.6 and 19.9±0.1 (°2θ);
• polymorphic form B, which has powder X-ray diffraction peaks at:
• 18.1 , 21.2 and 22.9±0.1 (°2θ);
• polymorphic form C;
• which has powder X-ray diffraction peaks at:
• 8.9, 11.7 and 20.3±0.1 (°2θ);
• polymorphic form D, which has powder X-ray diffraction peaks at:
• 17.1, 18.7 and 22.5±0.1 (°2θ);
• polymorphic form E, which has powder X-ray diffraction peaks at:
• 6.9, 13.0 and 19.8±0.1 (°2θ);
• polymorphic form F, which has powder X-ray diffraction peaks at:
• 5.3, 10.5 and 18.6+0.1 (°2θ);
• polymorphic form G, which has powder X-ray diffraction peaks at:
• 6.6, 19.2 and 20.4±0.1 (°2θ);
• or
• polymorphic form H, which has powder X-ray diffraction peaks at:
• 6.7, 19.5 and 19.8±0.1 (°2θ);
• or
• a 2-naphtylsulfonate salt of (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide in one of the following polymorphic forms:
• polymorphic form A+B, which has powder X-ray diffraction peaks at:
• 4.6, 18.5 and 23.8 ±0.1 (°2θ);
• polymorphic form A+B, which has powder X-ray diffraction peaks at:
• 4.7, 6.8 and 18.5 ±0.1 (°2θ);
• or
• polymorphic form C, which has powder X-ray diffraction peaks at:
• 5.8, 17.3 and 22.9±0.1 (°2θ).